Pandemic Influenza Vaccine H5n1 Astrazeneca

A/Vietnam/1203/2004 (H5N1) strain, the active ingredient in Pandemic Influenza Vaccine H5N1 Astrazeneca, is a vaccine presented as a nasal formulation for intranasal use. It is intended to prevent pandemic influenza caused by the H5N1 virus in at‑risk populations.

GNH USA supplies Pandemic Influenza Vaccine H5N1 Astrazeneca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established cold‑chain logistics and regulatory support for global distribution. The company ensures product integrity through temperature‑controlled handling and provides documentation to meet import and health authority requirements.

Pandemic Influenza Vaccine H5N1 Astrazeneca is used within the influenza vaccine family to provide prophylactic protection against H5N1 virus infection. - Pandemic influenza (H5N1): Provides immunity that reduces the risk of infection with the avian H5N1 influenza virus. - High‑risk populations (e.g., healthcare workers, travelers to endemic areas): Lowers the likelihood of acquiring H5N1 during exposure. - Outbreak response (regional or global H5N1 outbreaks): Supports rapid immunization campaigns to contain spread. - Public health emergency response: Enables authorities to vaccinate communities quickly during an H5N1 emergency.

Common Side Effects: - Nasal irritation or mild congestion. - Low‑grade fever. - Headache. - Transient fatigue.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Guillain‑Barré syndrome. - Severe respiratory distress or bronchospasm.

Precautions should be observed before administration. - Pregnancy: Use only if potential benefits outweigh uncertain risks. - Breastfeeding: Consider possible exposure to infant; weigh benefits against unknown risks. - Immunocompromised individuals: Vaccine may elicit a reduced immune response. - Known hypersensitivity: Avoid if patient has a documented allergy to any vaccine component. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Potential interactions have been identified. Major Interactions (Avoid): - Live attenuated vaccines: Concurrent use may diminish immune response to either product. - Immunoglobulin therapy: May neutralize vaccine antigen and reduce effectiveness. Moderate Interactions (Monitor Closely): - Antipyretics (e.g., acetaminophen) taken prophylactically: May blunt antibody production. - Immunosuppressive drugs: Can lower vaccine‑induced immunity. - Co‑administration with other vaccines on the same day: Monitor for additive local or systemic reactions.